ViroPharma

                   

ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute...

yahoo.com
2 hrs ago 1 related
        

ViroPharma Incorporated today announced that the company submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration for Cinryze C1 Inhibitor as a treatment for acute attacks of hereditary...

add comment
                   

The FDA's Killing Bug Killers (at Motley Fool)

yahoo.com
Nov 29, 2008 5 related
        

By Brian Orelli November 28, 2008 | Comments (0) It's not good enough for a company just to have clinical trial data showing that its drug works; the Food and Drug Administration has to actually believe that the data is real....

add comment

ViroPharma To Present At The 20th Annual Piper

pharmiweb.co.uk
Nov 26, 2008
        

Description: EXTON, Pa., Nov. 25 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the 20th Annual Piper...

add comment

ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference (PR Newswire)

yahoo.com
Nov 25, 2008 4 related
        

Tuesday November 25, 3:08 pm ET EXTON, Pa., Nov. 25 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM - News ) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present...

add comment

Coverage initiated on ViroPharma by Oppenheimer (Briefing.com)

yahoo.com
Nov 22, 2008 27 related
        

To learn more about Yahoo!'s use of personal information, please read the Privacy Policy. Analyst Summary Information (upgrades/downgrades module) provided by Briefing.com. All information provided "as is" for informational...

add comment

Top Biotech Short-Squeeze Plays (at TheStreet.com)

yahoo.com
Nov 22, 2008
        

One industry that is expected to do well in a Barack Obama presidency is biotech. With the drop in the stock market bringing down all stocks, including the biotechs, short-squeeze opportunities may exist. A short squeeze takes...

add comment

Oppenheimer takes cautious view on ViroPharma

ibtimes.com
Nov 21, 2008 2 related
        

Oppenheimer & Co. started coverage on ViroPharma Inc. Friday with a "Perform" rating, taking a cautious position on the company over concern that competitors for its core products are closer to reaching the market.

add comment

Movers roundup: KeyCorp, TiVo (AP)

yahoo.com
Nov 21, 2008
        

KeyCorp shares tumbled Friday, as investors punished the regional bank for slashing its dividend for the second time in five months and continued to flee financial stocks amid concerns about the stability of the sector.

add comment
yahoo.com: Reuters Deals Today yahoo.com

CORRECTED - UPDATE - Targanta drug seen similar to rivals-FDA (at Reuters)

yahoo.com
Nov 18, 2008 28 related
        

Updates shares to close, adds drug details) By Susan Heavey NEW YORK, Nov 17 (Reuters) - Targanta Therapeutics Corp's (TARG.O: ) clinical trial data show its antibiotic is about as safe and effective as current treatments, Food...

add comment

ViroPharma(GAAP) (VPHM.GP) Weekly Earnings Information

pharmiweb.co.uk
Nov 16, 2008
        

Released : Sunday, November 16, 2008 4:16 AM Company: ViroPharma(GAAP) (VPHM.GP) Actual EPS for FY End (12/2007): 1.21 Current FY High EPS Estimate: 1.06 Current FY Low EPS Estimate: 0.91 Current FY Consensus Estimate: 0.99...

add comment
1 2 3 next